Metabolically healthy obesity: facts and fantasies
Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted defin...
Gespeichert in:
Veröffentlicht in: | The Journal of clinical investigation 2019-10, Vol.129 (10), p.3978-3989 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3989 |
---|---|
container_issue | 10 |
container_start_page | 3978 |
container_title | The Journal of clinical investigation |
container_volume | 129 |
creator | Smith, Gordon I Mittendorfer, Bettina Klein, Samuel |
description | Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease. |
doi_str_mv | 10.1172/JCI129186 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A605723042</galeid><sourcerecordid>A605723042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhoModq1e-AdkQZD2Ymq-Jsl4IZTF6pZKwa_bkMmc2U3JJnWSKe6_N0vrslv2QnKRkDx5TsJ5EXpN8Bkhkr6_nM0JbYgST9CE1LWqFGXqKZpgTEnVSKaO0IuUbjAmnNf8OTpipKZcMDxB9Ctk00bvrPF-PV2C8Xm5nsYWksvrD9Pe2JymJnRlFbJJDtJL9Kw3PsGrh_kY_bz49GP2pbq6_jyfnV9VVhKWK1IqtI0SRvFO0dpaqazpbd3YXgrRE9rWjeKMgrGqxtj2IKXtOkI4BcXAsGP08d57O7Yr6CyEPBivbwe3MsNaR-P0_klwS72Id1pIwSjlRXDyIBji7xFS1iuXLHhvAsQxaUob3Ahc8w369hF6E8chlO9pyjAjggu1Qy2MB-1CH0tdu5Hq8-KRBeW0UNUBagEByiNjgN6V7T3-7ABfRgcrZw9eON27UJgMf_LCjCnp-fdv_89e_9pn3-2w91FI0Y_ZxZAOSu0QUxqg3zaFYL1JpN4msrBvdru4Jf9FkP0FM-zVcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2303164684</pqid></control><display><type>article</type><title>Metabolically healthy obesity: facts and fantasies</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Smith, Gordon I ; Mittendorfer, Bettina ; Klein, Samuel</creator><creatorcontrib>Smith, Gordon I ; Mittendorfer, Bettina ; Klein, Samuel</creatorcontrib><description>Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI129186</identifier><identifier>PMID: 31524630</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adipose tissue ; Analysis ; Animal models ; Biomedical research ; Body fat ; Body weight gain ; Cholesterol ; Clinical outcomes ; Diabetes ; Glucose ; Heart ; Homeostasis ; Insulin ; Insulin resistance ; Metabolic syndrome ; Obesity ; Review Series ; Studies ; Type 2 diabetes ; Womens health</subject><ispartof>The Journal of clinical investigation, 2019-10, Vol.129 (10), p.3978-3989</ispartof><rights>COPYRIGHT 2019 American Society for Clinical Investigation</rights><rights>Copyright American Society for Clinical Investigation Oct 2019</rights><rights>2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</citedby><cites>FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763224/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763224/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31524630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Gordon I</creatorcontrib><creatorcontrib>Mittendorfer, Bettina</creatorcontrib><creatorcontrib>Klein, Samuel</creatorcontrib><title>Metabolically healthy obesity: facts and fantasies</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.</description><subject>Adipose tissue</subject><subject>Analysis</subject><subject>Animal models</subject><subject>Biomedical research</subject><subject>Body fat</subject><subject>Body weight gain</subject><subject>Cholesterol</subject><subject>Clinical outcomes</subject><subject>Diabetes</subject><subject>Glucose</subject><subject>Heart</subject><subject>Homeostasis</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Metabolic syndrome</subject><subject>Obesity</subject><subject>Review Series</subject><subject>Studies</subject><subject>Type 2 diabetes</subject><subject>Womens health</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkl1rFDEUhoModq1e-AdkQZD2Ymq-Jsl4IZTF6pZKwa_bkMmc2U3JJnWSKe6_N0vrslv2QnKRkDx5TsJ5EXpN8Bkhkr6_nM0JbYgST9CE1LWqFGXqKZpgTEnVSKaO0IuUbjAmnNf8OTpipKZcMDxB9Ctk00bvrPF-PV2C8Xm5nsYWksvrD9Pe2JymJnRlFbJJDtJL9Kw3PsGrh_kY_bz49GP2pbq6_jyfnV9VVhKWK1IqtI0SRvFO0dpaqazpbd3YXgrRE9rWjeKMgrGqxtj2IKXtOkI4BcXAsGP08d57O7Yr6CyEPBivbwe3MsNaR-P0_klwS72Id1pIwSjlRXDyIBji7xFS1iuXLHhvAsQxaUob3Ahc8w369hF6E8chlO9pyjAjggu1Qy2MB-1CH0tdu5Hq8-KRBeW0UNUBagEByiNjgN6V7T3-7ABfRgcrZw9eON27UJgMf_LCjCnp-fdv_89e_9pn3-2w91FI0Y_ZxZAOSu0QUxqg3zaFYL1JpN4msrBvdru4Jf9FkP0FM-zVcA</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Smith, Gordon I</creator><creator>Mittendorfer, Bettina</creator><creator>Klein, Samuel</creator><general>American Society for Clinical Investigation</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20191001</creationdate><title>Metabolically healthy obesity: facts and fantasies</title><author>Smith, Gordon I ; Mittendorfer, Bettina ; Klein, Samuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c713t-1246b986a84d825cc78cafc59cf766f12b598432eac8500cfe77cdd1142e83ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipose tissue</topic><topic>Analysis</topic><topic>Animal models</topic><topic>Biomedical research</topic><topic>Body fat</topic><topic>Body weight gain</topic><topic>Cholesterol</topic><topic>Clinical outcomes</topic><topic>Diabetes</topic><topic>Glucose</topic><topic>Heart</topic><topic>Homeostasis</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Metabolic syndrome</topic><topic>Obesity</topic><topic>Review Series</topic><topic>Studies</topic><topic>Type 2 diabetes</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Gordon I</creatorcontrib><creatorcontrib>Mittendorfer, Bettina</creatorcontrib><creatorcontrib>Klein, Samuel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Gordon I</au><au>Mittendorfer, Bettina</au><au>Klein, Samuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolically healthy obesity: facts and fantasies</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>129</volume><issue>10</issue><spage>3978</spage><epage>3989</epage><pages>3978-3989</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Although obesity is typically associated with metabolic dysfunction and cardiometabolic diseases, some people with obesity are protected from many of the adverse metabolic effects of excess body fat and are considered "metabolically healthy." However, there is no universally accepted definition of metabolically healthy obesity (MHO). Most studies define MHO as having either 0, 1, or 2 metabolic syndrome components, whereas many others define MHO using the homeostasis model assessment of insulin resistance (HOMA-IR). Therefore, numerous people reported as having MHO are not metabolically healthy, but simply have fewer metabolic abnormalities than those with metabolically unhealthy obesity (MUO). Nonetheless, a small subset of people with obesity have a normal HOMA-IR and no metabolic syndrome components. The mechanism(s) responsible for the divergent effects of obesity on metabolic health is not clear, but studies conducted in rodent models suggest that differences in adipose tissue biology in response to weight gain can cause or prevent systemic metabolic dysfunction. In this article, we review the definition, stability over time, and clinical outcomes of MHO, and discuss the potential factors that could explain differences in metabolic health in people with MHO and MUO - specifically, modifiable lifestyle factors and adipose tissue biology. Better understanding of the factors that distinguish people with MHO and MUO can produce new insights into mechanism(s) responsible for obesity-related metabolic dysfunction and disease.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>31524630</pmid><doi>10.1172/JCI129186</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9738 |
ispartof | The Journal of clinical investigation, 2019-10, Vol.129 (10), p.3978-3989 |
issn | 0021-9738 1558-8238 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763224 |
source | PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library |
subjects | Adipose tissue Analysis Animal models Biomedical research Body fat Body weight gain Cholesterol Clinical outcomes Diabetes Glucose Heart Homeostasis Insulin Insulin resistance Metabolic syndrome Obesity Review Series Studies Type 2 diabetes Womens health |
title | Metabolically healthy obesity: facts and fantasies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T15%3A41%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolically%20healthy%20obesity:%20facts%20and%20fantasies&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Smith,%20Gordon%20I&rft.date=2019-10-01&rft.volume=129&rft.issue=10&rft.spage=3978&rft.epage=3989&rft.pages=3978-3989&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI129186&rft_dat=%3Cgale_pubme%3EA605723042%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2303164684&rft_id=info:pmid/31524630&rft_galeid=A605723042&rfr_iscdi=true |